[1]赵保健.心肌肌钙蛋白Ⅰ的临床应用及检测方法进展[J].国际放射医学核医学杂志,2003,27(5):212-215.
 ZHAO Bao-jian.The cinical utilization and development of assay for cardiac troponin I[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(5):212-215.
点击复制

心肌肌钙蛋白Ⅰ的临床应用及检测方法进展(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
27
期数:
2003年第5期
页码:
212-215
栏目:
核医学
出版日期:
1900-01-01

文章信息/Info

Title:
The cinical utilization and development of assay for cardiac troponin I
作者:
赵保健
300192 天津, 中国医学科学院中国协和医科大学放射医学研究所
Author(s):
ZHAO Bao-jian
The Instilute of Radiation Medicine, Chinese Academy of Medical Science, Peking Union Medical College, Tianjin 300192, China
关键词:
心肌肌钙蛋白I心肌损伤酶联免疫分析化学发光免疫分析
Keywords:
cardiac troponin Imyocardiac injuryenzyme-linked immunosorbent assaychemiluminoimmunoassay
分类号:
R446.62
摘要:
cTnI(心肌肌钙蛋白Ⅰ)是心肌肌钙蛋白的一种亚型,正常人血液中含量很低,当心肌细胞损伤时,cTnI在血液中的含量迅速升高。近年来随着cTnI检测方法的不断改进,cTnI已成为最具有临床价值的心肌损伤标志物之一,被广泛应用于心脏疾患的临床诊断和检测。
Abstract:
Cardiac troponin I (cTnI)is one of the subunits of cardiac troponin.Only a small amou-nt of cTnI can be found in normal serum.Its concentration increases rapidly when myocardiac cells is damaged.With the gradually improvement of analytical methods of cTnI,it has been extensively used to help clinical diagnosis and monitor the therapeutic efficacy of cardiac diseases.

参考文献/References:

[1] Jaffe AS,Landt Y,Parvin CA, et al. Comparative sensitivity of cardiac troponin I and lactate dehydrogenase isoenzymes for diagnosing acute myocardial infarction[J]. Clin Chem,1996,42: 1770-1776.
[2] Qin WS,Ling MF,Zhang XC,et al. Degradation of cardiac troponin I in serum complicates comparisons of cardiac troponin I assays[J]. Clin Chem, 1999, 45: 1018-1025.
[3] Apple FS,Falahati A,Paulsen PD,et al. Improved detection of minor ischemic myocardiac injury with measurement of serum cardiac troponin I[J]. Clin Chem,1997,43: 2047-2051.
[4] Apple FS. Tissue specificy of cardiac troponin I,cardiac troponin Tand creatine Jinase-MB[J]. Clin Chim Acta,1999, 284: 151-159.
[5] Mair J. Cardiac troponin I and troponin T: are enzymes still relevant as cardiac markers?[J]. Clin Chim Acta,1997, 257: 99-115.
[6] Matetzkys S,SharirT,Domingo M,et al. Elevated troponin I level on admission is associated with adverse outcome of primary angioplasty in acute myocardial infarction[J]. Cir-culation, 2000, 102: 1611-1616.
[7] Wu AHB. Cardiac markers: from enzymes to proteins,diagnosis to prognosis,laboratory to beside[J]. Ann Clin Lab Sci, 1999, 29: 18-23.
[8] Giuliani I,Bertinchant JP,Lopez M,et al. Determination of cardiac troponin I forms in the blood of patients with unstable angina pectoris[J]. Clin Biochem,2002, 32: 111-117.
[9] Olatidoye AG,Wu AHB,Yue-jin feng,et al. Prognostic role of troponin T versus I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies[J]. Am J Cardiol,1998, 81: 1405-1410.
[10] Dey JMD,Madrid AH,Valina JM,et al. Cardiac troponin I and minor cardiac damage: biochemical markers in a clinical model of myocardial lesions[J]. Clin Chem,1998,454: 2270-2277.
[11] Ricchiuti V, Shear WS, Henry TD, et al. Monitoring plasma cardiac troponin I for the detection of myocardial injury after percutaneous transluminal coronary angioplasty[J]. Clin Chim Acta, 2000, 302:161-170.
[12] Haggart PC, Adam DJ, Ludman PF, et al. Comparison of cardiac troponin I and creatine kinase ratios in the detection of myocardial injury after aortic surgery[J]. Br J Surg, 2001, 88: 1196-1200.
[13] Geiger DU, Wu AHB, Apple FS, et al. Multicenter evaluation of an automated assay for troponin I[J]. Clin Chem, 2002,48: 869-876.
[14] Heeschen C, Goldmann BU, Langenbrink L, et al. Evaluation of a rapid whole blood ELISA for quantification of troponin I in patients with acute chest pain[J]. Clin Chem, 1999, 45: 1789-1796.
[15] Hafner G, Peetz D, Erbes H, et al. Comparison of diagnostic performance of cardiac troponin I on the IMMULITE system with other automated troponin I assays in minor myocardial damage[J]. Scand J Clin Lab Invest, 2001, 61: 227-236.
[16] Katrukha AG, Bereznikova AV, Esakova TV, et al. Troponin I is released in bloodstream of patients with acute myocar-diac infarction not in free form but as complex[J]. Clin Chem, 1997,43: 1379-1385.
[17] Bunk DM, Dalluge JJ, Welch MJ. Heterogeneity in human cardiac Troponin I stardards[J]. Anal Biochem, 2000, 284: 191-200.
[18] Katrukha AG, Bereznikova AV, Filatov VL, et al. Degradation of cardiac troponin I: implication for reliable immun-odetection[J]. Clin Chem, 1998, 44: 2433-2440.
[19] Larue C, Defacque-Lacquement H, Calzolari C, et al. New monoclonal antibodies as probes for human cardiac troponin I: epitopic analysis with synthetic peptides[J]. Mol Immunol, 1992, 29,271-278.
[20] Katrukha AG, Bereznikova AV, Pettersson K, et al. New approach to standardization of human cardiac troponin I(cTnI)[J]. Scand J Clin Lab Invest, 1999, 59 Suppl 230): 124-127.
[21] Wu AHB, Apple FS, Warshaw MM, et al. National Academy of Clinical Biochemistry stardards of laboratory practice: recommendations for the use of cardiac makers in coronary artery diseases. Vol.5[M]. Washington, DC: National Academy of Clinical Biochemistry, 1999. 44.

相似文献/References:

[1]陈冀莹.心肌损伤标志物的应用及临床意义[J].国际放射医学核医学杂志,2004,28(5):216.
 CHEN Ji-ying.The application and clinical value of markers of myocardial damage[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(5):216.
[2]李波.心肌肌钙蛋白T及其在某些心脏疾患中的应用[J].国际放射医学核医学杂志,2000,24(5):205.
 LI Bo.The study of cardiac troponin T and clinical utilization in some myocardial diseases[J].International Journal of Radiation Medicine and Nuclear Medicine,2000,24(5):205.

备注/Memo

备注/Memo:
收稿日期:2003-05-22
作者简介:赵保健(1978-),男,硕士研究生,主要从事抗体制备研究。
更新日期/Last Update: 1900-01-01